<LCTL_TEXT lang="spa">
<DOC grammar="none" id="L0C04ATLT" lang="spa" raw_text_char_length="1717" raw_text_md5="34243250a7484f7f54e17f40f6a8f9f0" tokenization="tokenization_parameters.v5.0">
<TEXT>
<SEG end_char="72" id="segment-0" start_char="1">
<ORIGINAL_TEXT>Ученые оценили эффективность другого способа защиты человека от COVID-19</ORIGINAL_TEXT>
<TOKEN end_char="6" id="token-0-0" morph="none" pos="word" start_char="1">Ученые</TOKEN>
<TOKEN end_char="14" id="token-0-1" morph="none" pos="word" start_char="8">оценили</TOKEN>
<TOKEN end_char="28" id="token-0-2" morph="none" pos="word" start_char="16">эффективность</TOKEN>
<TOKEN end_char="36" id="token-0-3" morph="none" pos="word" start_char="30">другого</TOKEN>
<TOKEN end_char="44" id="token-0-4" morph="none" pos="word" start_char="38">способа</TOKEN>
<TOKEN end_char="51" id="token-0-5" morph="none" pos="word" start_char="46">защиты</TOKEN>
<TOKEN end_char="60" id="token-0-6" morph="none" pos="word" start_char="53">человека</TOKEN>
<TOKEN end_char="63" id="token-0-7" morph="none" pos="word" start_char="62">от</TOKEN>
<TOKEN end_char="72" id="token-0-8" morph="none" pos="unknown" start_char="65">COVID-19</TOKEN>
<TRANSLATED_TEXT>Scientists assessed the effectiveness of another method of protecting human beings from COVID-19</TRANSLATED_TEXT><DETECTED_LANGUAGE>ru</DETECTED_LANGUAGE></SEG>
<SEG end_char="221" id="segment-1" start_char="76">
<ORIGINAL_TEXT>У большинства тех, кто перенес COVID-19 без симптомов, выработались T-клетки, сигнализирующие о столкновении с инфекцией, показывают исследования.</ORIGINAL_TEXT>
<TOKEN end_char="76" id="token-1-0" morph="none" pos="word" start_char="76">У</TOKEN>
<TOKEN end_char="88" id="token-1-1" morph="none" pos="word" start_char="78">большинства</TOKEN>
<TOKEN end_char="92" id="token-1-2" morph="none" pos="word" start_char="90">тех</TOKEN>
<TOKEN end_char="93" id="token-1-3" morph="none" pos="punct" start_char="93">,</TOKEN>
<TOKEN end_char="97" id="token-1-4" morph="none" pos="word" start_char="95">кто</TOKEN>
<TOKEN end_char="105" id="token-1-5" morph="none" pos="word" start_char="99">перенес</TOKEN>
<TOKEN end_char="114" id="token-1-6" morph="none" pos="unknown" start_char="107">COVID-19</TOKEN>
<TOKEN end_char="118" id="token-1-7" morph="none" pos="word" start_char="116">без</TOKEN>
<TOKEN end_char="128" id="token-1-8" morph="none" pos="word" start_char="120">симптомов</TOKEN>
<TOKEN end_char="129" id="token-1-9" morph="none" pos="punct" start_char="129">,</TOKEN>
<TOKEN end_char="142" id="token-1-10" morph="none" pos="word" start_char="131">выработались</TOKEN>
<TOKEN end_char="151" id="token-1-11" morph="none" pos="unknown" start_char="144">T-клетки</TOKEN>
<TOKEN end_char="152" id="token-1-12" morph="none" pos="punct" start_char="152">,</TOKEN>
<TOKEN end_char="168" id="token-1-13" morph="none" pos="word" start_char="154">сигнализирующие</TOKEN>
<TOKEN end_char="170" id="token-1-14" morph="none" pos="word" start_char="170">о</TOKEN>
<TOKEN end_char="183" id="token-1-15" morph="none" pos="word" start_char="172">столкновении</TOKEN>
<TOKEN end_char="185" id="token-1-16" morph="none" pos="word" start_char="185">с</TOKEN>
<TOKEN end_char="195" id="token-1-17" morph="none" pos="word" start_char="187">инфекцией</TOKEN>
<TOKEN end_char="196" id="token-1-18" morph="none" pos="punct" start_char="196">,</TOKEN>
<TOKEN end_char="207" id="token-1-19" morph="none" pos="word" start_char="198">показывают</TOKEN>
<TOKEN end_char="220" id="token-1-20" morph="none" pos="word" start_char="209">исследования</TOKEN>
<TOKEN end_char="221" id="token-1-21" morph="none" pos="punct" start_char="221">.</TOKEN>
<TRANSLATED_TEXT>Most patients with COVID-19 without symptoms have developed T-cells that signal a collision with infection.</TRANSLATED_TEXT><DETECTED_LANGUAGE>ru</DETECTED_LANGUAGE></SEG>
<SEG end_char="298" id="segment-2" start_char="223">
<ORIGINAL_TEXT>Ученые рассказали РБК, как это можно использовать для борьбы с коронавирусом</ORIGINAL_TEXT>
<TOKEN end_char="228" id="token-2-0" morph="none" pos="word" start_char="223">Ученые</TOKEN>
<TOKEN end_char="239" id="token-2-1" morph="none" pos="word" start_char="230">рассказали</TOKEN>
<TOKEN end_char="243" id="token-2-2" morph="none" pos="word" start_char="241">РБК</TOKEN>
<TOKEN end_char="244" id="token-2-3" morph="none" pos="punct" start_char="244">,</TOKEN>
<TOKEN end_char="248" id="token-2-4" morph="none" pos="word" start_char="246">как</TOKEN>
<TOKEN end_char="252" id="token-2-5" morph="none" pos="word" start_char="250">это</TOKEN>
<TOKEN end_char="258" id="token-2-6" morph="none" pos="word" start_char="254">можно</TOKEN>
<TOKEN end_char="271" id="token-2-7" morph="none" pos="word" start_char="260">использовать</TOKEN>
<TOKEN end_char="275" id="token-2-8" morph="none" pos="word" start_char="273">для</TOKEN>
<TOKEN end_char="282" id="token-2-9" morph="none" pos="word" start_char="277">борьбы</TOKEN>
<TOKEN end_char="284" id="token-2-10" morph="none" pos="word" start_char="284">с</TOKEN>
<TOKEN end_char="298" id="token-2-11" morph="none" pos="word" start_char="286">коронавирусом</TOKEN>
<TRANSLATED_TEXT>Scientists told RBCs how to use it to control coronavirus</TRANSLATED_TEXT><DETECTED_LANGUAGE>ru</DETECTED_LANGUAGE></SEG>
<SEG end_char="632" id="segment-3" start_char="302">
<ORIGINAL_TEXT>Отрицательный анализ на антитела к вирусу SARS-CoV-2 не означает, что человек не болел коронавирусной инфекцией, у таких людей отпор вирусу могли дать Т-лимфоциты, рассказал РБК заведующий лабораторией трансплантационной иммунологии Национального медицинского исследовательского центра (НМИЦ) гематологии Минздрава Григорий Ефимов.</ORIGINAL_TEXT>
<TOKEN end_char="314" id="token-3-0" morph="none" pos="word" start_char="302">Отрицательный</TOKEN>
<TOKEN end_char="321" id="token-3-1" morph="none" pos="word" start_char="316">анализ</TOKEN>
<TOKEN end_char="324" id="token-3-2" morph="none" pos="word" start_char="323">на</TOKEN>
<TOKEN end_char="333" id="token-3-3" morph="none" pos="word" start_char="326">антитела</TOKEN>
<TOKEN end_char="335" id="token-3-4" morph="none" pos="word" start_char="335">к</TOKEN>
<TOKEN end_char="342" id="token-3-5" morph="none" pos="word" start_char="337">вирусу</TOKEN>
<TOKEN end_char="353" id="token-3-6" morph="none" pos="unknown" start_char="344">SARS-CoV-2</TOKEN>
<TOKEN end_char="356" id="token-3-7" morph="none" pos="word" start_char="355">не</TOKEN>
<TOKEN end_char="365" id="token-3-8" morph="none" pos="word" start_char="358">означает</TOKEN>
<TOKEN end_char="366" id="token-3-9" morph="none" pos="punct" start_char="366">,</TOKEN>
<TOKEN end_char="370" id="token-3-10" morph="none" pos="word" start_char="368">что</TOKEN>
<TOKEN end_char="378" id="token-3-11" morph="none" pos="word" start_char="372">человек</TOKEN>
<TOKEN end_char="381" id="token-3-12" morph="none" pos="word" start_char="380">не</TOKEN>
<TOKEN end_char="387" id="token-3-13" morph="none" pos="word" start_char="383">болел</TOKEN>
<TOKEN end_char="402" id="token-3-14" morph="none" pos="word" start_char="389">коронавирусной</TOKEN>
<TOKEN end_char="412" id="token-3-15" morph="none" pos="word" start_char="404">инфекцией</TOKEN>
<TOKEN end_char="413" id="token-3-16" morph="none" pos="punct" start_char="413">,</TOKEN>
<TOKEN end_char="415" id="token-3-17" morph="none" pos="word" start_char="415">у</TOKEN>
<TOKEN end_char="421" id="token-3-18" morph="none" pos="word" start_char="417">таких</TOKEN>
<TOKEN end_char="427" id="token-3-19" morph="none" pos="word" start_char="423">людей</TOKEN>
<TOKEN end_char="433" id="token-3-20" morph="none" pos="word" start_char="429">отпор</TOKEN>
<TOKEN end_char="440" id="token-3-21" morph="none" pos="word" start_char="435">вирусу</TOKEN>
<TOKEN end_char="446" id="token-3-22" morph="none" pos="word" start_char="442">могли</TOKEN>
<TOKEN end_char="451" id="token-3-23" morph="none" pos="word" start_char="448">дать</TOKEN>
<TOKEN end_char="463" id="token-3-24" morph="none" pos="unknown" start_char="453">Т-лимфоциты</TOKEN>
<TOKEN end_char="464" id="token-3-25" morph="none" pos="punct" start_char="464">,</TOKEN>
<TOKEN end_char="474" id="token-3-26" morph="none" pos="word" start_char="466">рассказал</TOKEN>
<TOKEN end_char="478" id="token-3-27" morph="none" pos="word" start_char="476">РБК</TOKEN>
<TOKEN end_char="489" id="token-3-28" morph="none" pos="word" start_char="480">заведующий</TOKEN>
<TOKEN end_char="502" id="token-3-29" morph="none" pos="word" start_char="491">лабораторией</TOKEN>
<TOKEN end_char="521" id="token-3-30" morph="none" pos="word" start_char="504">трансплантационной</TOKEN>
<TOKEN end_char="533" id="token-3-31" morph="none" pos="word" start_char="523">иммунологии</TOKEN>
<TOKEN end_char="547" id="token-3-32" morph="none" pos="word" start_char="535">Национального</TOKEN>
<TOKEN end_char="560" id="token-3-33" morph="none" pos="word" start_char="549">медицинского</TOKEN>
<TOKEN end_char="579" id="token-3-34" morph="none" pos="word" start_char="562">исследовательского</TOKEN>
<TOKEN end_char="586" id="token-3-35" morph="none" pos="word" start_char="581">центра</TOKEN>
<TOKEN end_char="588" id="token-3-36" morph="none" pos="punct" start_char="588">(</TOKEN>
<TOKEN end_char="592" id="token-3-37" morph="none" pos="word" start_char="589">НМИЦ</TOKEN>
<TOKEN end_char="593" id="token-3-38" morph="none" pos="punct" start_char="593">)</TOKEN>
<TOKEN end_char="605" id="token-3-39" morph="none" pos="word" start_char="595">гематологии</TOKEN>
<TOKEN end_char="615" id="token-3-40" morph="none" pos="word" start_char="607">Минздрава</TOKEN>
<TOKEN end_char="624" id="token-3-41" morph="none" pos="word" start_char="617">Григорий</TOKEN>
<TOKEN end_char="631" id="token-3-42" morph="none" pos="word" start_char="626">Ефимов</TOKEN>
<TOKEN end_char="632" id="token-3-43" morph="none" pos="punct" start_char="632">.</TOKEN>
<TRANSLATED_TEXT>A negative analysis of antibodies to SARS-CoV-2 does not mean that the person did not have a coronavirus infection, such people may have been resistant to the virus by T-lymphocytes, told RBC Head of Laboratory of Transplantation Immunology of the National Medical Research Centre (NMIC) of Hematology of the Ministry of Health Grigory Efimov.</TRANSLATED_TEXT><DETECTED_LANGUAGE>ru</DETECTED_LANGUAGE></SEG>
<SEG end_char="753" id="segment-4" start_char="635">
<ORIGINAL_TEXT>По его словам, чем легче перенес коронавирус человек, тем выше вероятность того, что у него не будут выявлены антитела.</ORIGINAL_TEXT>
<TOKEN end_char="636" id="token-4-0" morph="none" pos="word" start_char="635">По</TOKEN>
<TOKEN end_char="640" id="token-4-1" morph="none" pos="word" start_char="638">его</TOKEN>
<TOKEN end_char="647" id="token-4-2" morph="none" pos="word" start_char="642">словам</TOKEN>
<TOKEN end_char="648" id="token-4-3" morph="none" pos="punct" start_char="648">,</TOKEN>
<TOKEN end_char="652" id="token-4-4" morph="none" pos="word" start_char="650">чем</TOKEN>
<TOKEN end_char="658" id="token-4-5" morph="none" pos="word" start_char="654">легче</TOKEN>
<TOKEN end_char="666" id="token-4-6" morph="none" pos="word" start_char="660">перенес</TOKEN>
<TOKEN end_char="678" id="token-4-7" morph="none" pos="word" start_char="668">коронавирус</TOKEN>
<TOKEN end_char="686" id="token-4-8" morph="none" pos="word" start_char="680">человек</TOKEN>
<TOKEN end_char="687" id="token-4-9" morph="none" pos="punct" start_char="687">,</TOKEN>
<TOKEN end_char="691" id="token-4-10" morph="none" pos="word" start_char="689">тем</TOKEN>
<TOKEN end_char="696" id="token-4-11" morph="none" pos="word" start_char="693">выше</TOKEN>
<TOKEN end_char="708" id="token-4-12" morph="none" pos="word" start_char="698">вероятность</TOKEN>
<TOKEN end_char="713" id="token-4-13" morph="none" pos="word" start_char="710">того</TOKEN>
<TOKEN end_char="714" id="token-4-14" morph="none" pos="punct" start_char="714">,</TOKEN>
<TOKEN end_char="718" id="token-4-15" morph="none" pos="word" start_char="716">что</TOKEN>
<TOKEN end_char="720" id="token-4-16" morph="none" pos="word" start_char="720">у</TOKEN>
<TOKEN end_char="725" id="token-4-17" morph="none" pos="word" start_char="722">него</TOKEN>
<TOKEN end_char="728" id="token-4-18" morph="none" pos="word" start_char="727">не</TOKEN>
<TOKEN end_char="734" id="token-4-19" morph="none" pos="word" start_char="730">будут</TOKEN>
<TOKEN end_char="743" id="token-4-20" morph="none" pos="word" start_char="736">выявлены</TOKEN>
<TOKEN end_char="752" id="token-4-21" morph="none" pos="word" start_char="745">антитела</TOKEN>
<TOKEN end_char="753" id="token-4-22" morph="none" pos="punct" start_char="753">.</TOKEN>
<TRANSLATED_TEXT>According to him, the easier it is for a person to get coronavirus, the more likely it is that he will not have antibodies.</TRANSLATED_TEXT><DETECTED_LANGUAGE>ru</DETECTED_LANGUAGE></SEG>
<SEG end_char="952" id="segment-5" start_char="755">
<ORIGINAL_TEXT>Об этом уже свидетельствуют данные нескольких научных работ, в том числе исследование, организованное на базе НМИЦ гематологии совместно с учеными из других российских университетов, говорит Ефимов.</ORIGINAL_TEXT>
<TOKEN end_char="756" id="token-5-0" morph="none" pos="word" start_char="755">Об</TOKEN>
<TOKEN end_char="761" id="token-5-1" morph="none" pos="word" start_char="758">этом</TOKEN>
<TOKEN end_char="765" id="token-5-2" morph="none" pos="word" start_char="763">уже</TOKEN>
<TOKEN end_char="781" id="token-5-3" morph="none" pos="word" start_char="767">свидетельствуют</TOKEN>
<TOKEN end_char="788" id="token-5-4" morph="none" pos="word" start_char="783">данные</TOKEN>
<TOKEN end_char="799" id="token-5-5" morph="none" pos="word" start_char="790">нескольких</TOKEN>
<TOKEN end_char="807" id="token-5-6" morph="none" pos="word" start_char="801">научных</TOKEN>
<TOKEN end_char="813" id="token-5-7" morph="none" pos="word" start_char="809">работ</TOKEN>
<TOKEN end_char="814" id="token-5-8" morph="none" pos="punct" start_char="814">,</TOKEN>
<TOKEN end_char="816" id="token-5-9" morph="none" pos="word" start_char="816">в</TOKEN>
<TOKEN end_char="820" id="token-5-10" morph="none" pos="word" start_char="818">том</TOKEN>
<TOKEN end_char="826" id="token-5-11" morph="none" pos="word" start_char="822">числе</TOKEN>
<TOKEN end_char="839" id="token-5-12" morph="none" pos="word" start_char="828">исследование</TOKEN>
<TOKEN end_char="840" id="token-5-13" morph="none" pos="punct" start_char="840">,</TOKEN>
<TOKEN end_char="855" id="token-5-14" morph="none" pos="word" start_char="842">организованное</TOKEN>
<TOKEN end_char="858" id="token-5-15" morph="none" pos="word" start_char="857">на</TOKEN>
<TOKEN end_char="863" id="token-5-16" morph="none" pos="word" start_char="860">базе</TOKEN>
<TOKEN end_char="868" id="token-5-17" morph="none" pos="word" start_char="865">НМИЦ</TOKEN>
<TOKEN end_char="880" id="token-5-18" morph="none" pos="word" start_char="870">гематологии</TOKEN>
<TOKEN end_char="890" id="token-5-19" morph="none" pos="word" start_char="882">совместно</TOKEN>
<TOKEN end_char="892" id="token-5-20" morph="none" pos="word" start_char="892">с</TOKEN>
<TOKEN end_char="900" id="token-5-21" morph="none" pos="word" start_char="894">учеными</TOKEN>
<TOKEN end_char="903" id="token-5-22" morph="none" pos="word" start_char="902">из</TOKEN>
<TOKEN end_char="910" id="token-5-23" morph="none" pos="word" start_char="905">других</TOKEN>
<TOKEN end_char="921" id="token-5-24" morph="none" pos="word" start_char="912">российских</TOKEN>
<TOKEN end_char="935" id="token-5-25" morph="none" pos="word" start_char="923">университетов</TOKEN>
<TOKEN end_char="936" id="token-5-26" morph="none" pos="punct" start_char="936">,</TOKEN>
<TOKEN end_char="944" id="token-5-27" morph="none" pos="word" start_char="938">говорит</TOKEN>
<TOKEN end_char="951" id="token-5-28" morph="none" pos="word" start_char="946">Ефимов</TOKEN>
<TOKEN end_char="952" id="token-5-29" morph="none" pos="punct" start_char="952">.</TOKEN>
<TRANSLATED_TEXT>This has already been demonstrated by data from several scientific works, including a study organized on the basis of NMIC haematology together with scientists from other Russian universities, says Efimov.</TRANSLATED_TEXT><DETECTED_LANGUAGE>ru</DETECTED_LANGUAGE></SEG>
<SEG end_char="1121" id="segment-6" start_char="955">
<ORIGINAL_TEXT>В исследовании, результаты которого уже были опубликованы в авторитетном американском журнале Immunity, принимали участие сотрудники и студенты МГУ и НМИЦ гематологии.</ORIGINAL_TEXT>
<TOKEN end_char="955" id="token-6-0" morph="none" pos="word" start_char="955">В</TOKEN>
<TOKEN end_char="968" id="token-6-1" morph="none" pos="word" start_char="957">исследовании</TOKEN>
<TOKEN end_char="969" id="token-6-2" morph="none" pos="punct" start_char="969">,</TOKEN>
<TOKEN end_char="980" id="token-6-3" morph="none" pos="word" start_char="971">результаты</TOKEN>
<TOKEN end_char="989" id="token-6-4" morph="none" pos="word" start_char="982">которого</TOKEN>
<TOKEN end_char="993" id="token-6-5" morph="none" pos="word" start_char="991">уже</TOKEN>
<TOKEN end_char="998" id="token-6-6" morph="none" pos="word" start_char="995">были</TOKEN>
<TOKEN end_char="1011" id="token-6-7" morph="none" pos="word" start_char="1000">опубликованы</TOKEN>
<TOKEN end_char="1013" id="token-6-8" morph="none" pos="word" start_char="1013">в</TOKEN>
<TOKEN end_char="1026" id="token-6-9" morph="none" pos="word" start_char="1015">авторитетном</TOKEN>
<TOKEN end_char="1039" id="token-6-10" morph="none" pos="word" start_char="1028">американском</TOKEN>
<TOKEN end_char="1047" id="token-6-11" morph="none" pos="word" start_char="1041">журнале</TOKEN>
<TOKEN end_char="1056" id="token-6-12" morph="none" pos="word" start_char="1049">Immunity</TOKEN>
<TOKEN end_char="1057" id="token-6-13" morph="none" pos="punct" start_char="1057">,</TOKEN>
<TOKEN end_char="1067" id="token-6-14" morph="none" pos="word" start_char="1059">принимали</TOKEN>
<TOKEN end_char="1075" id="token-6-15" morph="none" pos="word" start_char="1069">участие</TOKEN>
<TOKEN end_char="1086" id="token-6-16" morph="none" pos="word" start_char="1077">сотрудники</TOKEN>
<TOKEN end_char="1088" id="token-6-17" morph="none" pos="word" start_char="1088">и</TOKEN>
<TOKEN end_char="1097" id="token-6-18" morph="none" pos="word" start_char="1090">студенты</TOKEN>
<TOKEN end_char="1101" id="token-6-19" morph="none" pos="word" start_char="1099">МГУ</TOKEN>
<TOKEN end_char="1103" id="token-6-20" morph="none" pos="word" start_char="1103">и</TOKEN>
<TOKEN end_char="1108" id="token-6-21" morph="none" pos="word" start_char="1105">НМИЦ</TOKEN>
<TOKEN end_char="1120" id="token-6-22" morph="none" pos="word" start_char="1110">гематологии</TOKEN>
<TOKEN end_char="1121" id="token-6-23" morph="none" pos="punct" start_char="1121">.</TOKEN>
<TRANSLATED_TEXT>The study, the results of which have already been published in the authoritative American journal Immunity, was attended by staff and students of the MSU and the NMIC Hematology.</TRANSLATED_TEXT><DETECTED_LANGUAGE>ru</DETECTED_LANGUAGE></SEG>
<SEG end_char="1233" id="segment-7" start_char="1123">
<ORIGINAL_TEXT>Всего, по словам Ефимова, это 34 переболевших добровольца и две группы здоровых доноров по 14 и десять человек.</ORIGINAL_TEXT>
<TOKEN end_char="1127" id="token-7-0" morph="none" pos="word" start_char="1123">Всего</TOKEN>
<TOKEN end_char="1128" id="token-7-1" morph="none" pos="punct" start_char="1128">,</TOKEN>
<TOKEN end_char="1131" id="token-7-2" morph="none" pos="word" start_char="1130">по</TOKEN>
<TOKEN end_char="1138" id="token-7-3" morph="none" pos="word" start_char="1133">словам</TOKEN>
<TOKEN end_char="1146" id="token-7-4" morph="none" pos="word" start_char="1140">Ефимова</TOKEN>
<TOKEN end_char="1147" id="token-7-5" morph="none" pos="punct" start_char="1147">,</TOKEN>
<TOKEN end_char="1151" id="token-7-6" morph="none" pos="word" start_char="1149">это</TOKEN>
<TOKEN end_char="1154" id="token-7-7" morph="none" pos="word" start_char="1153">34</TOKEN>
<TOKEN end_char="1167" id="token-7-8" morph="none" pos="word" start_char="1156">переболевших</TOKEN>
<TOKEN end_char="1179" id="token-7-9" morph="none" pos="word" start_char="1169">добровольца</TOKEN>
<TOKEN end_char="1181" id="token-7-10" morph="none" pos="word" start_char="1181">и</TOKEN>
<TOKEN end_char="1185" id="token-7-11" morph="none" pos="word" start_char="1183">две</TOKEN>
<TOKEN end_char="1192" id="token-7-12" morph="none" pos="word" start_char="1187">группы</TOKEN>
<TOKEN end_char="1201" id="token-7-13" morph="none" pos="word" start_char="1194">здоровых</TOKEN>
<TOKEN end_char="1209" id="token-7-14" morph="none" pos="word" start_char="1203">доноров</TOKEN>
<TOKEN end_char="1212" id="token-7-15" morph="none" pos="word" start_char="1211">по</TOKEN>
<TOKEN end_char="1215" id="token-7-16" morph="none" pos="word" start_char="1214">14</TOKEN>
<TOKEN end_char="1217" id="token-7-17" morph="none" pos="word" start_char="1217">и</TOKEN>
<TOKEN end_char="1224" id="token-7-18" morph="none" pos="word" start_char="1219">десять</TOKEN>
<TOKEN end_char="1232" id="token-7-19" morph="none" pos="word" start_char="1226">человек</TOKEN>
<TOKEN end_char="1233" id="token-7-20" morph="none" pos="punct" start_char="1233">.</TOKEN>
<TRANSLATED_TEXT>In total, according to Efimov, there are 34 sick volunteers and two groups of healthy donors of 14 and 10.</TRANSLATED_TEXT><DETECTED_LANGUAGE>ru</DETECTED_LANGUAGE></SEG>
<SEG end_char="1309" id="segment-8" start_char="1236">
<ORIGINAL_TEXT>«Мы изучали, как у них устроен антительный и Т-клеточный [иммунный] ответ.</ORIGINAL_TEXT>
<TOKEN end_char="1236" id="token-8-0" morph="none" pos="punct" start_char="1236">«</TOKEN>
<TOKEN end_char="1238" id="token-8-1" morph="none" pos="word" start_char="1237">Мы</TOKEN>
<TOKEN end_char="1246" id="token-8-2" morph="none" pos="word" start_char="1240">изучали</TOKEN>
<TOKEN end_char="1247" id="token-8-3" morph="none" pos="punct" start_char="1247">,</TOKEN>
<TOKEN end_char="1251" id="token-8-4" morph="none" pos="word" start_char="1249">как</TOKEN>
<TOKEN end_char="1253" id="token-8-5" morph="none" pos="word" start_char="1253">у</TOKEN>
<TOKEN end_char="1257" id="token-8-6" morph="none" pos="word" start_char="1255">них</TOKEN>
<TOKEN end_char="1265" id="token-8-7" morph="none" pos="word" start_char="1259">устроен</TOKEN>
<TOKEN end_char="1277" id="token-8-8" morph="none" pos="word" start_char="1267">антительный</TOKEN>
<TOKEN end_char="1279" id="token-8-9" morph="none" pos="word" start_char="1279">и</TOKEN>
<TOKEN end_char="1291" id="token-8-10" morph="none" pos="unknown" start_char="1281">Т-клеточный</TOKEN>
<TOKEN end_char="1293" id="token-8-11" morph="none" pos="punct" start_char="1293">[</TOKEN>
<TOKEN end_char="1301" id="token-8-12" morph="none" pos="word" start_char="1294">иммунный</TOKEN>
<TOKEN end_char="1302" id="token-8-13" morph="none" pos="punct" start_char="1302">]</TOKEN>
<TOKEN end_char="1308" id="token-8-14" morph="none" pos="word" start_char="1304">ответ</TOKEN>
<TOKEN end_char="1309" id="token-8-15" morph="none" pos="punct" start_char="1309">.</TOKEN>
<TRANSLATED_TEXT>We 've been studying how they have antibodies and T-cell [immune] responses.</TRANSLATED_TEXT><DETECTED_LANGUAGE>ru</DETECTED_LANGUAGE></SEG>
<SEG end_char="1390" id="segment-9" start_char="1311">
<ORIGINAL_TEXT>У подавляющей части переболевших, у которых нет антител, есть Т-клеточный ответ.</ORIGINAL_TEXT>
<TOKEN end_char="1311" id="token-9-0" morph="none" pos="word" start_char="1311">У</TOKEN>
<TOKEN end_char="1323" id="token-9-1" morph="none" pos="word" start_char="1313">подавляющей</TOKEN>
<TOKEN end_char="1329" id="token-9-2" morph="none" pos="word" start_char="1325">части</TOKEN>
<TOKEN end_char="1342" id="token-9-3" morph="none" pos="word" start_char="1331">переболевших</TOKEN>
<TOKEN end_char="1343" id="token-9-4" morph="none" pos="punct" start_char="1343">,</TOKEN>
<TOKEN end_char="1345" id="token-9-5" morph="none" pos="word" start_char="1345">у</TOKEN>
<TOKEN end_char="1353" id="token-9-6" morph="none" pos="word" start_char="1347">которых</TOKEN>
<TOKEN end_char="1357" id="token-9-7" morph="none" pos="word" start_char="1355">нет</TOKEN>
<TOKEN end_char="1365" id="token-9-8" morph="none" pos="word" start_char="1359">антител</TOKEN>
<TOKEN end_char="1366" id="token-9-9" morph="none" pos="punct" start_char="1366">,</TOKEN>
<TOKEN end_char="1371" id="token-9-10" morph="none" pos="word" start_char="1368">есть</TOKEN>
<TOKEN end_char="1383" id="token-9-11" morph="none" pos="unknown" start_char="1373">Т-клеточный</TOKEN>
<TOKEN end_char="1389" id="token-9-12" morph="none" pos="word" start_char="1385">ответ</TOKEN>
<TOKEN end_char="1390" id="token-9-13" morph="none" pos="punct" start_char="1390">.</TOKEN>
<TRANSLATED_TEXT>The vast majority of patients who do not have antibodies have a T-cell.................</TRANSLATED_TEXT><DETECTED_LANGUAGE>ru</DETECTED_LANGUAGE></SEG>
<SEG end_char="1713" id="segment-10" start_char="1392">
<ORIGINAL_TEXT>В другом исследовании мы набирали специально людей без антител, которые были в тесном контакте с больными, они не заболели сами и антител не выработали, и выяснили: у большего процента среди них есть Т-лимфоциты», — рассказал Ефимов РБК, пояснив, что последняя категория, вероятнее всего, перенесла COVID-19 без симптомов.</ORIGINAL_TEXT>
<TOKEN end_char="1392" id="token-10-0" morph="none" pos="word" start_char="1392">В</TOKEN>
<TOKEN end_char="1399" id="token-10-1" morph="none" pos="word" start_char="1394">другом</TOKEN>
<TOKEN end_char="1412" id="token-10-2" morph="none" pos="word" start_char="1401">исследовании</TOKEN>
<TOKEN end_char="1415" id="token-10-3" morph="none" pos="word" start_char="1414">мы</TOKEN>
<TOKEN end_char="1424" id="token-10-4" morph="none" pos="word" start_char="1417">набирали</TOKEN>
<TOKEN end_char="1435" id="token-10-5" morph="none" pos="word" start_char="1426">специально</TOKEN>
<TOKEN end_char="1441" id="token-10-6" morph="none" pos="word" start_char="1437">людей</TOKEN>
<TOKEN end_char="1445" id="token-10-7" morph="none" pos="word" start_char="1443">без</TOKEN>
<TOKEN end_char="1453" id="token-10-8" morph="none" pos="word" start_char="1447">антител</TOKEN>
<TOKEN end_char="1454" id="token-10-9" morph="none" pos="punct" start_char="1454">,</TOKEN>
<TOKEN end_char="1462" id="token-10-10" morph="none" pos="word" start_char="1456">которые</TOKEN>
<TOKEN end_char="1467" id="token-10-11" morph="none" pos="word" start_char="1464">были</TOKEN>
<TOKEN end_char="1469" id="token-10-12" morph="none" pos="word" start_char="1469">в</TOKEN>
<TOKEN end_char="1476" id="token-10-13" morph="none" pos="word" start_char="1471">тесном</TOKEN>
<TOKEN end_char="1485" id="token-10-14" morph="none" pos="word" start_char="1478">контакте</TOKEN>
<TOKEN end_char="1487" id="token-10-15" morph="none" pos="word" start_char="1487">с</TOKEN>
<TOKEN end_char="1496" id="token-10-16" morph="none" pos="word" start_char="1489">больными</TOKEN>
<TOKEN end_char="1497" id="token-10-17" morph="none" pos="punct" start_char="1497">,</TOKEN>
<TOKEN end_char="1501" id="token-10-18" morph="none" pos="word" start_char="1499">они</TOKEN>
<TOKEN end_char="1504" id="token-10-19" morph="none" pos="word" start_char="1503">не</TOKEN>
<TOKEN end_char="1513" id="token-10-20" morph="none" pos="word" start_char="1506">заболели</TOKEN>
<TOKEN end_char="1518" id="token-10-21" morph="none" pos="word" start_char="1515">сами</TOKEN>
<TOKEN end_char="1520" id="token-10-22" morph="none" pos="word" start_char="1520">и</TOKEN>
<TOKEN end_char="1528" id="token-10-23" morph="none" pos="word" start_char="1522">антител</TOKEN>
<TOKEN end_char="1531" id="token-10-24" morph="none" pos="word" start_char="1530">не</TOKEN>
<TOKEN end_char="1542" id="token-10-25" morph="none" pos="word" start_char="1533">выработали</TOKEN>
<TOKEN end_char="1543" id="token-10-26" morph="none" pos="punct" start_char="1543">,</TOKEN>
<TOKEN end_char="1545" id="token-10-27" morph="none" pos="word" start_char="1545">и</TOKEN>
<TOKEN end_char="1554" id="token-10-28" morph="none" pos="word" start_char="1547">выяснили</TOKEN>
<TOKEN end_char="1555" id="token-10-29" morph="none" pos="punct" start_char="1555">:</TOKEN>
<TOKEN end_char="1557" id="token-10-30" morph="none" pos="word" start_char="1557">у</TOKEN>
<TOKEN end_char="1566" id="token-10-31" morph="none" pos="word" start_char="1559">большего</TOKEN>
<TOKEN end_char="1575" id="token-10-32" morph="none" pos="word" start_char="1568">процента</TOKEN>
<TOKEN end_char="1581" id="token-10-33" morph="none" pos="word" start_char="1577">среди</TOKEN>
<TOKEN end_char="1585" id="token-10-34" morph="none" pos="word" start_char="1583">них</TOKEN>
<TOKEN end_char="1590" id="token-10-35" morph="none" pos="word" start_char="1587">есть</TOKEN>
<TOKEN end_char="1602" id="token-10-36" morph="none" pos="unknown" start_char="1592">Т-лимфоциты</TOKEN>
<TOKEN end_char="1604" id="token-10-37" morph="none" pos="punct" start_char="1603">»,</TOKEN>
<TOKEN end_char="1606" id="token-10-38" morph="none" pos="punct" start_char="1606">—</TOKEN>
<TOKEN end_char="1616" id="token-10-39" morph="none" pos="word" start_char="1608">рассказал</TOKEN>
<TOKEN end_char="1623" id="token-10-40" morph="none" pos="word" start_char="1618">Ефимов</TOKEN>
<TOKEN end_char="1627" id="token-10-41" morph="none" pos="word" start_char="1625">РБК</TOKEN>
<TOKEN end_char="1628" id="token-10-42" morph="none" pos="punct" start_char="1628">,</TOKEN>
<TOKEN end_char="1636" id="token-10-43" morph="none" pos="word" start_char="1630">пояснив</TOKEN>
<TOKEN end_char="1637" id="token-10-44" morph="none" pos="punct" start_char="1637">,</TOKEN>
<TOKEN end_char="1641" id="token-10-45" morph="none" pos="word" start_char="1639">что</TOKEN>
<TOKEN end_char="1651" id="token-10-46" morph="none" pos="word" start_char="1643">последняя</TOKEN>
<TOKEN end_char="1661" id="token-10-47" morph="none" pos="word" start_char="1653">категория</TOKEN>
<TOKEN end_char="1662" id="token-10-48" morph="none" pos="punct" start_char="1662">,</TOKEN>
<TOKEN end_char="1672" id="token-10-49" morph="none" pos="word" start_char="1664">вероятнее</TOKEN>
<TOKEN end_char="1678" id="token-10-50" morph="none" pos="word" start_char="1674">всего</TOKEN>
<TOKEN end_char="1679" id="token-10-51" morph="none" pos="punct" start_char="1679">,</TOKEN>
<TOKEN end_char="1689" id="token-10-52" morph="none" pos="word" start_char="1681">перенесла</TOKEN>
<TOKEN end_char="1698" id="token-10-53" morph="none" pos="unknown" start_char="1691">COVID-19</TOKEN>
<TOKEN end_char="1702" id="token-10-54" morph="none" pos="word" start_char="1700">без</TOKEN>
<TOKEN end_char="1712" id="token-10-55" morph="none" pos="word" start_char="1704">симптомов</TOKEN>
<TOKEN end_char="1713" id="token-10-56" morph="none" pos="punct" start_char="1713">.</TOKEN>
<TRANSLATED_TEXT>In another study we specifically recruited people without antibodies who were in close contact with the patients, they did not develop the disease themselves and found: more percent of them have T lymphocytes, "Efimov told RBC, explaining that the last category most likely carried COVID-19 without symptoms.</TRANSLATED_TEXT><DETECTED_LANGUAGE>ru</DETECTED_LANGUAGE></SEG>
</TEXT>
</DOC>
</LCTL_TEXT>